Search Clinical Trials
Before medications are approved by the U.S. Food and Drug Administration (FDA) or before certain therapy methods are widely accepted as effective, they are tested on people who volunteer to participate in a clinical trial.
Organizations across the country are looking for people like you to take part in their research studies. The list of studies below have been selected from ClinicalTrials.gov based on their inclusion of one or more of the following terms: anxiety disorders, depression, OCD, PTSD, and bipolar disorder.
The Anxiety and Depression Association of America (ADAA) is supportive of research that is conducted through clinical trials. Participating in research can potentially help change the mental health outcomes for you and others who suffer anxiety, depression, and related disorders. You may learn about new interventions/treatments that are being considered.
Read this ADAA blog about things to know and questions to ask before committing to a clinical trial.
This website page is brought to you in partnership with ResearchMatch.
| Sponsor Condition of Interest |
|---|
|
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
NYU Langone Health
Depression
MDD
Major Depressive Disorder
Major Depressive Episode
This pilot study evaluates the feasibility, safety, and preliminary efficacy of
home-based 60Hz intermittent light therapy in adults with a major depressive episode
(MDE). Participants will be randomized in a 2:1 ratio to receive either active or sham
60Hz intermittent light stimulation for 30 minu1 expand
This pilot study evaluates the feasibility, safety, and preliminary efficacy of home-based 60Hz intermittent light therapy in adults with a major depressive episode (MDE). Participants will be randomized in a 2:1 ratio to receive either active or sham 60Hz intermittent light stimulation for 30 minutes daily (Monday through Friday) over three weeks. The light is delivered through a wearable headset. Clinical assessments will be conducted remotely at baseline, mid-point, post-treatment, and follow-up to measure changes in depressive symptoms. Type: Interventional Start Date: Aug 2025 |
|
A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
Florida International University
Depressive Symptoms
Hiv
The goal of this randomized clinical trial is to learn if tai chi/qigong decreases
depressive symptoms among older people living with HIV compared to a health education
class. The main questions it aims to answer are:
Does tai chi/qigong reduce depressive symptoms among older people living with HI1 expand
The goal of this randomized clinical trial is to learn if tai chi/qigong decreases depressive symptoms among older people living with HIV compared to a health education class. The main questions it aims to answer are: Does tai chi/qigong reduce depressive symptoms among older people living with HIV more than a health education class? What are the behavioral, psychological, and biological mechanisms in which tai chi/qigong affects depressive symptoms? Does tai chi/qigong affect depressive symptoms among older people living with HIV differently for men compared to women? Researchers will compare a 12-week, twice a week remotely delivered tai chi/qigong intervention to a health education class of the same duration to determine if it improves depressive symptoms among older people living with HIV. Participants will: Attend either a tai chi/qigong class twice a week for 12 weeks or a health education class of the same duration delivered via Zoom. Each class will be 45-60 minutes in length. Participate in 3 separate interviewer-administered interviews: at the time of enrollment, 3 months after the last class, and 9 months after the last class. Keep a tracking log of their home practice of tai chi/qigong (only participants in the intervention group). Use a biosensor (an earlobe sensor or chest strap) to measure their heart variability. Go to their local lab (e.g., Quest or Labcorp) for blood draw at the time of enrollment and at 9 month post intervention (this will only be a subset of participants). Type: Interventional Start Date: Aug 2025 |
|
Intervention Trial for Healthcare Workers With Anxiety
University of California, Los Angeles
Anxiety
The purpose of the study is to conduct an initial test of the efficacy of Emotional
Resolution (EmRes) therapy to reduce anxiety in healthcare workers. The investigators
hypothesize EmRes will reduce levels of anxiety in participants compared to an active
control group engaged in mindfulness-based1 expand
The purpose of the study is to conduct an initial test of the efficacy of Emotional Resolution (EmRes) therapy to reduce anxiety in healthcare workers. The investigators hypothesize EmRes will reduce levels of anxiety in participants compared to an active control group engaged in mindfulness-based gratitude. Type: Interventional Start Date: Oct 2024 |
|
Virtual Patient Navigation During a Pandemic
Children's Hospital of Philadelphia
Post-partum Depression
The sub-study will involve a rigorous mixed-methods design. The qualitative phase of the
sub-study will consist of semi-structured interviews. During the semi-structured
interviews, 10 eligible women will be recruited to identify barriers and facilitators to
accessing virtual mental health services1 expand
The sub-study will involve a rigorous mixed-methods design. The qualitative phase of the sub-study will consist of semi-structured interviews. During the semi-structured interviews, 10 eligible women will be recruited to identify barriers and facilitators to accessing virtual mental health services. This information will be used to adapt an evidence-based patient navigation intervention for virtual use. For the intervention phase of the sub-study, 30 women with persistent postpartum depression symptoms will be recruited to participate in the adapted virtual navigator program using rapid cycle testing over a 2-month period. Type: Interventional Start Date: Jun 2023 |
|
A New Intervention to Improve Function in Veterans With Anxiety and Depression
VA Office of Research and Development
Anxiety and Depression
Anxiety and depression symptoms occur at high rates in Veteran populations and can
significantly impact function, compromising the ability to work and to successfully form
and maintain valued relationships. Several other symptoms commonly occur with anxiety and
depression, including poor sleep qual1 expand
Anxiety and depression symptoms occur at high rates in Veteran populations and can significantly impact function, compromising the ability to work and to successfully form and maintain valued relationships. Several other symptoms commonly occur with anxiety and depression, including poor sleep quality and chronic pain. Since all these symptoms frequently occur together, they may have a common underlying biological basis. A single medication that could effectively treat all these symptoms would be ideal. Converging data suggest that pregnenolone is a promising pharmacological agent for treating multiple psychiatric symptoms and functional impairment. The investigators thus propose to conduct a clinical trial of pregnenolone in Veterans with anxiety and depression symptoms. Pregnenolone has minimal side effects, and the prior research demonstrates that pregnenolone is well-tolerated by Veterans. Treatment with pregnenolone could thus be an efficacious new therapeutic for Veterans experiencing depression, anxiety, poor sleep quality and chronic pain conditions. Type: Interventional Start Date: Aug 2025 |
|
Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation
Weill Medical College of Cornell University
Depression
Elder Abuse
The purpose of this randomized trial is to conduct a fully powered effectiveness trial of
video-delivered PROTECT (Tele-PROTECT) compared to a video-delivered depression education
(DepEd) control condition to be delivered to 140 English- and Spanish-speaking NYC elder
abuse victims. Investigators h1 expand
The purpose of this randomized trial is to conduct a fully powered effectiveness trial of video-delivered PROTECT (Tele-PROTECT) compared to a video-delivered depression education (DepEd) control condition to be delivered to 140 English- and Spanish-speaking NYC elder abuse victims. Investigators hypothesize three main aims: 1. Effectiveness Aim: Tele-PROTECT participants will have significantly greater and clinically meaningful reductions in depression when compared to the DepEd control; 2. Abuse Impact Aim: Tele-PROTECT participants will demonstrate greater safety related empowerment compared to DepEd control, which can help participants take steps to reduce risk; 3. Implementation Aim: Stakeholders' views of the factors impacting the implementation of Tele-PROTECT based on characteristics of the intervention, agency setting, and population served will contribute to a national dissemination of Tele-PROTECT Participants will - Receive 9 weeks of tele health psychotherapy delivered by a Master's level mental health clinician from the Weill Cornell Medicine research team. Participants will be assigned to "Tele-PROTECT" or "DepEd" psychotherapy randomly. - Participate in one baseline assessment and four follow-up assessments at weeks 3, 6, 9, and 12 administered by a trained member of the research team. Type: Interventional Start Date: Sep 2023 |
|
A Study of Spoken Language in Mania
Mayo Clinic
Manic Episode
Bipolar I Disorder
This research is being done to find if there are changes with voice and speech during
episodes of mania. expand
This research is being done to find if there are changes with voice and speech during episodes of mania. Type: Interventional Start Date: Apr 2023 |
|
Network Neurofeedback Using 7-Tesla MRI to Reduce Rumination Levels in Depression
Icahn School of Medicine at Mount Sinai
Major Depressive Disorder
Patients with major depressive disorder (MDD) exhibit increased levels of rumination
(i.e. repetitive thinking and focus on negative mood states) which have been found to
increase the risk of depressive relapse. The ability to reduce rumination levels among
these patients is greatly needed. Ruminat1 expand
Patients with major depressive disorder (MDD) exhibit increased levels of rumination (i.e. repetitive thinking and focus on negative mood states) which have been found to increase the risk of depressive relapse. The ability to reduce rumination levels among these patients is greatly needed. Rumination is known to be associated with the default mode network (DMN) region activity. Implementing the Dependency Network Analysis (DEPNA), a recently developed method by the research team to quantify the connectivity influence of network nodes, found that rumination was significantly associated with lower connectivity influence of the left medial orbitofrontal cortex (MOFC) on the right precuneus, both key regions within the DMN. This study implements the first real-time fMRI neurofeedback (Rt-fMRI-NF) network-based protocol for up-regulation of the MOFC influence on the precuneus in patients with MDD to reduce rumination levels. This will allow for more accurate explicit brain connections modulation than the standard single brain region activity; creating a larger opportunity for target clinical neuromodulation treatment in individuals with MDD. Type: Interventional Start Date: Jul 2023 |
|
5-HTP and Creatine for Depression R33 Phase
University of Utah
Major Depressive Disorder
This is a three-armed clinical trial examining the effect of 5-hydroxytryptophan and
creatine monohydrate as augmenting agents for the treatment of depression. Subjects will
be randomized between 5-HTP 100mg BID + creatine 5g daily, 5-HTP 200mg BID + creatine 10g
daily, vs double placebo, for 8 wee1 expand
This is a three-armed clinical trial examining the effect of 5-hydroxytryptophan and creatine monohydrate as augmenting agents for the treatment of depression. Subjects will be randomized between 5-HTP 100mg BID + creatine 5g daily, 5-HTP 200mg BID + creatine 10g daily, vs double placebo, for 8 weeks. The ability of the interventions to affect biomarkers associated with depression will be assessed using brain phosphorus magnetic resonance spectroscopy, functional connectivity imaging, and plasma serotonin levels. Type: Interventional Start Date: Sep 2023 |
|
A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients
Mayo Clinic
Depression
The purpose of this research is to study the effects of intravenous ketamine infusions
for the treatment of patients with depressive symptoms in intensive care unit (ICU). expand
The purpose of this research is to study the effects of intravenous ketamine infusions for the treatment of patients with depressive symptoms in intensive care unit (ICU). Type: Interventional Start Date: Jul 2025 |
|
A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious M1
VA Office of Research and Development
Psychotic Disorders
Bipolar Disorders
Suicidal Ideation
Suicide, Attempted
Suicide is a major public health concern, particularly among Veterans with serious mental
illness (SMI, i.e., psychotic disorders or bipolar disorders). Wellness Recovery Action
Plan (WRAP) is a well-established evidence-based practice for those with SMI that centers
on identifying warning signs of1 expand
Suicide is a major public health concern, particularly among Veterans with serious mental illness (SMI, i.e., psychotic disorders or bipolar disorders). Wellness Recovery Action Plan (WRAP) is a well-established evidence-based practice for those with SMI that centers on identifying warning signs of mental illness, developing wellness tools for functional independence, planning for day-to-day effective living within one's community, and building an action plan to create a valued life worth living. This proposed study will refine and pilot SUicide Prevention by Peers Offering Recovery Tactics (SUPPORT), a novel integrated recovery program that is an adaptation of peer-delivered WRAP for Veterans with SMI. In SUPPORT, a Peer Specialist leads a Veteran at increased risk for suicide through recovery planning that is tailored to the Veteran's suicidal experiences with cognitive learning strategies to enhance safety plan recall and improve functioning. Type: Interventional Start Date: Sep 2023 |
|
Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Feder1
University of Michigan
PTSD
This trial is being completed to develop a stepped-care talk therapy model for patients
with PTSD. Specifically, this study is testing whether beginning with one type of therapy
is better than beginning with another type of therapy, and whether moving to a different
therapy after four sessions is m1 expand
This trial is being completed to develop a stepped-care talk therapy model for patients with PTSD. Specifically, this study is testing whether beginning with one type of therapy is better than beginning with another type of therapy, and whether moving to a different therapy after four sessions is more helpful than staying with the same therapy, depending on how well it is working. The central hypothesis is that beginning with a low- or medium-intensity PTSD intervention and then titrating intensity based on early indications of response will result in clinically significant PTSD symptom reduction with parsimony of resources. Type: Interventional Start Date: Jun 2022 |
|
Decoding and Modulating Affective Brain States
University of Pennsylvania
Rumination
Major Depressive Disorder
Anxiety
The research study is being conducted to study brain patterns of negative emotion and
develop personalized brain stimulation protocols to disrupt these patterns with
transcranial magnetic stimulation (TMS). First, the investigators will use functional
Magnetic Resonance Imaging (fMRI) data to gener1 expand
The research study is being conducted to study brain patterns of negative emotion and develop personalized brain stimulation protocols to disrupt these patterns with transcranial magnetic stimulation (TMS). First, the investigators will use functional Magnetic Resonance Imaging (fMRI) data to generate a negative affect map for each participant. Then, the investigators will apply a variety of repetitive transcranial magnetic stimulation (rTMS) sequences while the participant is inside the MRI scanner to determine the optimal and least optimal rTMS frequencies at changing negative affect brain states. Finally, these two frequencies will be tested over two 3-day rTMS neuromodulation sessions to assess whether they can reduce negative emotions. Type: Interventional Start Date: Feb 2023 |
|
Mental Health in Primary Care
University of Miami
Depression, Anxiety
Suicide
Drug Use
The goal of this study is to evaluate in an effectiveness-implementation type I hybrid
trial, an enhanced version of eHealth Familias Unidas for reducing depressive, anxious
symptoms and suicide behavior in Hispanic youth. The study will use a randomized rollout
design with 18 pediatric primary car1 expand
The goal of this study is to evaluate in an effectiveness-implementation type I hybrid trial, an enhanced version of eHealth Familias Unidas for reducing depressive, anxious symptoms and suicide behavior in Hispanic youth. The study will use a randomized rollout design with 18 pediatric primary care clinics in the South Florida area. Type: Interventional Start Date: Apr 2022 |
|
Treatments for Insomnia in Veterans With PTSD
VA Office of Research and Development
Insomnia
PTSD
This randomized trial will compare a novel treatment, Acceptance of the Behavioral
Changes to Treat Insomnia (ABC-I) to Cognitive Behavioral Therapy for Insomnia (CBT-I)
among Veterans with comorbid Post-Traumatic Stress Disorder (PTSD) and insomnia disorder.
ABC-I combines the behavioral component1 expand
This randomized trial will compare a novel treatment, Acceptance of the Behavioral Changes to Treat Insomnia (ABC-I) to Cognitive Behavioral Therapy for Insomnia (CBT-I) among Veterans with comorbid Post-Traumatic Stress Disorder (PTSD) and insomnia disorder. ABC-I combines the behavioral components of CBT-I with components of another behavioral therapy (Acceptance and Commitment Therapy) and has been shown to improve treatment adherence. The study objectives are: 1) to evaluate the benefits of ABC-I in reducing post-traumatic stress disorder (PTSD) symptoms among Veterans with comorbid PTSD and insomnia disorder compared to CBT-I, and 2) to evaluate the effectiveness of ABC-I in improving insomnia symptoms and sleep quality among Veterans with comorbid PTSD and insomnia disorder as compared to CBT-I. Veterans with insomnia and comorbid PTSD who receive care at Sepulveda and West Los Angeles facilities will be recruited for the study. Those who pass an initial eligibility screen will be enrolled and written informed consent will be obtained. A baseline assessment will be completed that includes measures of sleep, PTSD, and quality of life. Veterans who meet all eligibility criteria will be randomly assigned to the ABC-I (n=100) or CBT-I (n=100) treatment. Both treatments will be provided in 5 one-on-one sessions by a trained instructor who is supervised by a behavioral sleep medicine specialist. All randomized participants (n=200) will have 3 follow-up assessments (post-treatment, 3-months, and 6-months after randomization). The follow-up assessments will collect information on PTSD symptoms, insomnia symptoms and sleep quality. Type: Interventional Start Date: Sep 2022 |
|
Study of Dextromethorphan in OCD and Related Disorders
Stanford University
Obsessive-Compulsive Disorder
Illness Anxiety Disorder
Body Dysmorphic Disorders
Somatic Symptom Disorder
The purpose of the study is to assess the tolerability and efficacy of dextromethorphan
in combination with fluoxetine for symptom relief in OCD and related disorders. expand
The purpose of the study is to assess the tolerability and efficacy of dextromethorphan in combination with fluoxetine for symptom relief in OCD and related disorders. Type: Interventional Start Date: Jan 2022 |
|
Mechanisms of Rumination Change in Adolescent Depression
Ohio State University
Major Depressive Disorder
Mood Disorders
This study will evaluate whether a newer treatment, rumination-focused cognitive
behavioral treatment, which includes mindfulness and can be used to reduce ruminative
habits, change ways in which key brain regions interact with each other (e.g.., often
called connectivity), and whether these change1 expand
This study will evaluate whether a newer treatment, rumination-focused cognitive behavioral treatment, which includes mindfulness and can be used to reduce ruminative habits, change ways in which key brain regions interact with each other (e.g.., often called connectivity), and whether these changes in habits and brain connectivity can reduce the risk for recurrence of depression in the next two years. Type: Interventional Start Date: May 2019 |
|
RCT for Latina Mental Health Using Web-Based Apps
University of California, Los Angeles
Mental Health
Anxiety
Depression
Well-Being, Psychological
This study compares a choice-driven, interactive, evidence-informed storytelling
web-based app intervention with links to resources and treatment (Tx) recommendations
(made by a character via her blog) and Tx locator, to a web-based app with links to
publicly available informational internet videos1 expand
This study compares a choice-driven, interactive, evidence-informed storytelling web-based app intervention with links to resources and treatment (Tx) recommendations (made by a character via her blog) and Tx locator, to a web-based app with links to publicly available informational internet videos, MH resources, and a treatment locator for at least moderately anxious/depressed untreated English and Spanish speaking Latinas to determine if a story-based, character-driven approach is more effective for catalyzing mental health treatment initiation. Type: Interventional Start Date: Jun 2025 |
|
Application of Virtual Reality Technology to Treatment of Social Anxiety
The University of Texas Health Science Center, Houston
Autism Spectrum Disorder
Social Anxiety Disorder
The purpose of this study is to compare CBT VR exposure + VR social skills treatment to
CBT Imaginal exposure + mindfulness, in reducing the severity of social anxiety in adults
with autism and social anxiety (SA), to identify characteristics associated with
benefitting from the CBT-VR treatment an1 expand
The purpose of this study is to compare CBT VR exposure + VR social skills treatment to CBT Imaginal exposure + mindfulness, in reducing the severity of social anxiety in adults with autism and social anxiety (SA), to identify characteristics associated with benefitting from the CBT-VR treatment and to assess acceptability and feasibility of the VR intervention for patients receiving it and use findings to improve methods and to prepare for a community based pragmatic trial. Type: Interventional Start Date: Nov 2024 |
|
Suvorexant for Treatment of AUD and PTSD
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Alcohol Use Disorder (AUD)
Post Traumatic Stress Disorder (PTSD)
Insomnia
This study is to determine if suvorexant (SUV) will reduce insomnia in 76 men and women
veteran and non-veterans between the ages 21-65 with posttraumatic stress disorder (PTSD)
symptoms and alcohol use disorder (AUD). All participants will have a 7-day placebo
run-in period, followed by a random a1 expand
This study is to determine if suvorexant (SUV) will reduce insomnia in 76 men and women veteran and non-veterans between the ages 21-65 with posttraumatic stress disorder (PTSD) symptoms and alcohol use disorder (AUD). All participants will have a 7-day placebo run-in period, followed by a random assignment to receive placebo or suvorexant for an additonal 14 days. Post-randomization, participants will attempt to stop drinking for two weeks and will complete daily virtual diaries and study outcome assessments via in-person clinic visits on days 7 and 14. Type: Interventional Start Date: Jul 2025 |
|
A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With Depression
Juliana Zambrano, MD, MPH
Depression
This is a pilot clinical trial to assess the feasibility, safety, and preliminary
efficacy of ketamine-assisted group therapy for Spanish-speaking adults with depression expand
This is a pilot clinical trial to assess the feasibility, safety, and preliminary efficacy of ketamine-assisted group therapy for Spanish-speaking adults with depression Type: Interventional Start Date: Jul 2025 |
|
Accelerated rTMS for Substance Use Disorder and Depression
University of Texas Southwestern Medical Center
Stimulant Use
Depression
This study is a small open-label feasibility trial of an accelerated course of repetitive
transcranial magnetic stimulation (rTMS) for individuals with depression and stimulant
use disorder [including methamphetamine or cocaine use disorder (MUD/CUD)]. expand
This study is a small open-label feasibility trial of an accelerated course of repetitive transcranial magnetic stimulation (rTMS) for individuals with depression and stimulant use disorder [including methamphetamine or cocaine use disorder (MUD/CUD)]. Type: Interventional Start Date: Jun 2024 |
|
Optimizing Suicide Prevention Strategies for Pediatric Primary Care
University of Pittsburgh
Suicidal Ideation
Suicidal and Self-injurious Behavior
Depression
Increasing rates of suicidal thoughts and behaviors among adolescents must be addressed.
The study will adapt and collect preliminary effectiveness data on a digital suicide
prevention intervention that can be delivered in pediatric primary care settings by front
line pediatricians. The study has t1 expand
Increasing rates of suicidal thoughts and behaviors among adolescents must be addressed. The study will adapt and collect preliminary effectiveness data on a digital suicide prevention intervention that can be delivered in pediatric primary care settings by front line pediatricians. The study has the potential to offer a low-cost and scalable primary care intervention that may decrease risk of suicide among at-risk youth. Type: Interventional Start Date: Jun 2025 |
|
Better Sleep Study
University of California, San Francisco
Depression in Adolescence
Delayed Sleep Phase
The overall aim of this proposal is a confirmatory efficacy trial sufficiently powered
and designed to test the hypothesis that improving the relationship between biological
circadian timing and waketime, a novel modifiable target, improves depression outcomes in
a subgroup of adolescents with depr1 expand
The overall aim of this proposal is a confirmatory efficacy trial sufficiently powered and designed to test the hypothesis that improving the relationship between biological circadian timing and waketime, a novel modifiable target, improves depression outcomes in a subgroup of adolescents with depression and a misaligned relationship between biological circadian timing and waketime utilizing a cognitive-behavioral sleep intervention. Type: Interventional Start Date: Mar 2024 |
|
A Text Messaging Intervention to Reduce Perinatal Depression Risk
University of Massachusetts, Worcester
Major Depressive Episode
Development and preliminary testing of a text messaging intervention that will reduce the
risk of a major depressive episode and worsening depressive symptoms in perinatal
individuals. The system will screen pregnant individuals, send tailored text messages
with links to enhanced content, and will1 expand
Development and preliminary testing of a text messaging intervention that will reduce the risk of a major depressive episode and worsening depressive symptoms in perinatal individuals. The system will screen pregnant individuals, send tailored text messages with links to enhanced content, and will include a peer chat function.This accessible text platform will leverage both the ease of use inherent in text messages and the power of enhanced content drawn evidence from based behavioral interventions (Interpersonal Therapy). Type: Interventional Start Date: Sep 2024 |